๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

PDGFR-A is a therapeutic target in alveolar rhabdomyosarcoma

โœ Scribed by Taniguchi, E; Nishijo, K; McCleish, A T; Michalek, J E; Grayson, M H; Infante, A J; Abboud, H E; Legallo, R D; Qualman, S J; Rubin, B P


Book ID
109970581
Publisher
Nature Publishing Group
Year
2008
Tongue
English
Weight
431 KB
Volume
27
Category
Article
ISSN
0950-9232

No coin nor oath required. For personal study only.


๐Ÿ“œ SIMILAR VOLUMES


Is endotoxemia a therapeutic target in l
โœ Tetsuji Fujita ๐Ÿ“‚ Article ๐Ÿ“… 2011 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 296 KB

We read with interest the reviews by Ghouri et al. 1 and Martinez et al. 2 Ghouri et al. analyzed the association of nonalcoholic fatty liver disease (NAFLD) with cardiovascular disease (CVD) and concluded that although a diagnosis of NAFLD should prompt diabetes screening, it is insufficient for co

B-RAF is a therapeutic target in melanom
โœ Karasarides, Maria; Chiloeches, Antonio; Hayward, Robert; Niculescu-Duvaz, Dan; ๐Ÿ“‚ Article ๐Ÿ“… 2004 ๐Ÿ› Nature Publishing Group ๐ŸŒ English โš– 339 KB
PAX3-FOXO1 and FGFR4 in alveolar rhabdom
โœ Amy D. Marshall; Martijn A. van der Ent; Gerard C. Grosveld ๐Ÿ“‚ Article ๐Ÿ“… 2011 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 260 KB